Development of Acute Myocardial Infarction Mortality and Readmission Models for Public Reporting on Hospital Performance in Canada
ABSTRACT: Background: Given changes in the care and outcomes of acute myocardial infarction (AMI) patients over the past several decades, we sought to develop prediction models that could be used to generate accurate risk-adjusted mortality and readmission outcomes for hospitals in current practice...
Main Authors: | Dennis T. Ko, MD, MSc, Tareq Ahmed, MPH, Peter C. Austin, PhD, Warren J. Cantor, MD, Paul Dorian, MD, Michael Goldfarb, MD, MSc, Yanyan Gong, MSc, Michelle M. Graham, MD, Jing Gu, MD, PhD, Nathaniel M. Hawkins, MD, MPH, MBChB, Thao Huynh, MD, PhD, Karin H. Humphries, MBA, DSc, Maria Koh, MSc, Yoan Lamarche, MD, MSc, Laurie J. Lambert, PhD, Patrick R. Lawler, MD, MPH, Jean-Francois Légaré, MD, Hung Q. Ly, MD, Feng Qiu, MSc, Ata ur Rehman Quraishi, MBBS, Derek Y. So, MD, MSc, Robert C. Welsh, MD, Harindra C. Wijeysundera, MD, PhD, Graham Wong, MD, MPH, Andrew T. Yan, MD, FRCPC, Yana Gurevich, MD, MPH |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | CJC Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589790X21001207 |
Similar Items
-
Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
by: Michail Nikolaou MD, MSc, PhD, et al.
Published: (2019-01-01) -
Immunohistochemical Expression of Cyclooxygenases in Hypertrophic Scars and Keloids
by: Michel Pavelecini, MD, MSc, PhD, et al.
Published: (2019-02-01) -
Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation
by: Michael Spartalis, MD, MSc, PhD, et al.
Published: (2017-12-01) -
Health Outcomes of Infants in a PMTCT Program in Kinshasa
by: John Ditekemena MD, MPH, et al.
Published: (2015-09-01) -
Troponin Testing After Noncardiac Surgery in Ontario: An Observational Study
by: Paymon M. Azizi, MSc, et al.
Published: (2021-07-01)